Effect of Tumstatin T-7 Peptide on HepG-2 cells and Human Umbilical vein Endothelial cells
The direct anti-tumor T-7 peptide of tumstatin was obtained to study its effect on human hepatoma cells (HepG-2) and human umbilical vein endothelial cells (ECV304).T-7 peptide was synthesized and its purity was up to 98.5%.MTT assay,growth curve,transmission electron microscopy(TEM) were used to detect the proliferation inhibition and pro-apoptotic function.MTT experiments and growth curve experiments showed that the survival of human hepatoma cells (HepG-2) decreased in a time-and dose-dependent way with the concentration of T-7 peptide increased.T-7 peptide can induce apoptosis of HepG-2 significantly.Apoptosis features were observed by TEM.However,the inhibition ofT-7 peptide on human umbilical vein endothelial cells (ECV304) was weaker.Experiments showed thatT-7 peptide can affect HepG-2 cells.It had a certain therapeutic effect on human hepatocellular carcinoma.T-7 peptide have little effect on ECV304 cells,which means it didnt influence the formation of tumor angiogenesis and normal ceils.
tumstatin cell proliferation cell apoptosis hepatocarcinoma angiogenesis
Shujing Wang Fei Wang Jia Liu Shan Jiang Ning Chen Lin Liu Ying Zhao Xiaodan Zhang
College of pharmacy, Harbin University of Commerce, Harbin, Heilongjiang, China, 150076
国际会议
厦门
英文
744-747
2012-12-28(万方平台首次上网日期,不代表论文的发表时间)